About this course

  • Released: 10/24/2011
  • Expires: 10/25/2013

Learning Objectives:

Upon completion of the article by Stein et al, the participant should be able to:
• Discuss previous evidence for an association between 25-hydroxyvitamin D levels and MS
• Summarize the results of previous, uncontrolled studies assessing the administration of vitamin D or its precursors in MS
• Discuss the results of this study assessing high-dose vitamin D2 in relapsing-remitting multiple sclerosis

Core Competencies:

The article by Stein et al covers the following core competency:
• Medical Knowledge


Learning Objectives:

Upon completion of the article by Michelson et al, the participant should be able to:
• Define global developmental delay and intellectual disability in children
• Summarize the evidence regarding the diagnostic yield of genetic and metabolic evaluation of children with global developmental delay or intellectual disability (GDD/ID)
• Discuss the potential clinical significance and implications of genetic and metabolic testing of children with GDD/ID

Core Competencies:

The article by Michelson et al covers the following core competency:
• Medical Knowledge


Author Disclosures
Refer to listing above the references in each article.

THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES

ACCREDITATION STATEMENT

The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

MISSION STATEMENT/PROGRAM OBJECTIVES

After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.

PARTICIPANTS

This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.

CREDITS

The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.

The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.

DISCLOSURES

Steven Lewis, MD, has received personal compensation in an editorial capacity for the National Board of Medical Examiners and the American College of Physicians; Paul Schulz, MD, has received personal compensation for activities with Pfizer.

COMMERCIAL SUPPORT

This CME program receives no commercial support.

Content failed to load, please try again later.

ACCME